The APOE ε4 genotype modulates CSF YKL‐40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2-Reference-Cited by-同舟云学术

The APOE ε4 genotype modulates CSF YKL‐40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2

Published:2016-12-22 Issue:1 Volume:6 Page:50-59
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Gispert Juan Domingo¹²³,Monté Gemma C.⁴,Suárez‐Calvet Marc⁵⁶,Falcon Carles¹²,Tucholka Alan¹,Rojas Santiago¹⁷,Rami Lorena⁴,Sánchez‐Valle Raquel⁴,Lladó Albert⁴,Kleinberger Gernot⁵⁸,Haass Christian⁵⁶⁸,Molinuevo José Luis¹⁴

Affiliation:

1. Barcelonaβeta Brain Research Center, Pasqual Maragall FoundationBarcelonaSpain

2. Centro de Investigación Biomédica en Red de BioingenieríaBiomateriales y Nanomedicina (CIBER‐BBN)ZaragozaSpain

3. Pompeu Fabra UniversityBarcelonaSpain

4. Alzheimer's Disease and Other Cognitive Disorders UnitHospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)BarcelonaSpain

5. BioMedical Center (BMC), BiochemistryLudwig‐Maximilians‐University MunichMunichGermany

6. German Center for Neurodegenerative Diseases (DZNE) MunichMunichGermany

7. Unit of human Anatomy and Embryology, Department of Morphological Sciences, Faculty of MedicineAutonomous University of BarcelonaCerdanyola del VallèsSpain

8. Munich Cluster for Systems Neurology (SyNergy)MunichGermany

Funder

MetLife Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2016.12.002

Reference46 articles.

1. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria